866775-18-0

Basic information

• Product Name: Methyl 3-amino-6-bromo-5-(trifluoromethyl)picolinate
• Synonyms: Methyl 3-amino-6-bromo-5-(trifluoromethyl)picolinate;3-Amino-6-bromo-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester
• CAS NO: 866775-18-0
• Molecular Formula: C₈H₆BrF₃N₂O₂
• Molecular Weight: 299.0446496
• Mol File: 866775-18-0.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 356.5±42.0 °C(Predicted)
• Appearance: /
• Density: 1.733±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: -1.39±0.10(Predicted)
• CAS DataBase Reference: Methyl 3-amino-6-bromo-5-(trifluoromethyl)picolinate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 3-amino-6-bromo-5-(trifluoromethyl)picolinate(866775-18-0)
• EPA Substance Registry System: Methyl 3-amino-6-bromo-5-(trifluoromethyl)picolinate(866775-18-0)

Safety Data

• Hazardous Substances Data: 866775-18-0(Hazardous Substances Data)

Usage

General Description

Methyl 3-amino-6-bromo-5-(trifluoromethyl)picolinate is a chemical compound with the molecular formula C8H7BrF3N2O2. It is a picolinate derivative with a methyl group, an amino group, a bromine atom, and a trifluoromethyl group attached to the pyridine ring. Methyl 3-amino-6-bromo-5-(trifluoromethyl)picolinate is widely used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It has potential applications in the development of new drugs and can also be used as a building block for the preparation of various heterocyclic compounds. Due to its unique chemical structure, Methyl 3-amino-6-bromo-5-(trifluoromethyl)picolinate has attracted attention in the field of medicinal and agricultural chemistry for its diverse and valuable properties.

Upstream product

• 655235-65-7 methyl 3-chloro-5-(trifluoromethyl)pyridine-2-carboxylate 
• 72587-15-6 2-chloro-3-nitro-5-(trifluoromethyl)pyridine 
• 1211515-30-8 3-amino-5-(trifluoromethyl)picolinonitrile 
• 1214336-90-9 3-amino-6-(2,6-difluorophenyl)-5-trifluoromethyl-2-pyridinecarboxylicacid 
• 866775-17-9 3-amino-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester 
• 866775-16-8 3-nitro-5-trifluoromethyl-pyridine-2-carbonitrile 
• 33252-64-1 3-nitro-5-trifluoromethylpyridin-2-ol 

Downstream Products

• 1334547-23-7 3-amino-6-(2,4-dichlorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid methyl ester 
• 1334546-83-6 3-amino-6-(2,4-dichlorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid 
• 1334547-21-5 3-amino-6-(4-fluorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid 
• 1334546-80-3 3-amino-6-(4-fluorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid ((S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl)amide 
• 1427400-35-8 methyl 3-amino-6-(4-fluorophenyl)-5-(trifluoromethyl)picolinate 
• 1427400-25-6 3-amino-6-(4-fluorophenyl)-N-(1H-pyrazol-3-yl)-5-(trifluoromethyl)picolinamide 
• 1427262-80-3 (R)-2-(5-(amino(phenyl)methyl)-1,3,4-oxadiazol-2-yl)-6-bromo-5-(trifluoromethyl)pyridin-3-amine 
• 1427262-83-6 (R)-benzyl (5-(3-amino-6-bromo-5-(trifluoromethyl)pyridin-2-yl)-1,3,4-oxadiazol-2-yl)(phenyl)methylcarbamate 
• 1427262-81-4 (R)-benzyl 2-(2-(3-amino-6-bromo-5-(trifluoromethyl)picolinoyl)hydrazinyl)-2-oxo-1-phenylethylcarbamate 
• 1427262-60-9 2-(5-benzyl-1,3,4-oxadiazol-2-yl)-6-bromo-5-(trifluoromethyl)pyridin-3-amine 
• 1427262-61-0 3-amino-6-bromo-N'-(2-phenylacetyl)-5-(trifluoromethyl)picolinohydrazide 

Relevant articles and documents

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.

Pyridine and Pyrazine derivative for the Treatment of CF, COPD, and Bronchiectasis

The present invention provides pyridine and pyrazine derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (IBS, IBD, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed.

PYRIDINE/PYRAZINE AMIDE DERIVATIVES

The present invention provides pyridine/pyrazine amide derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthm